Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus
- 1 January 2017
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 137, 141-150
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR000101, UL1RR031975)
- National Institutes of Health
- National Institutes of Health (AI109185)
This publication has 49 references indexed in Scilit:
- Autophagy modulation as a potential therapeutic target for diverse diseasesNature Reviews Drug Discovery, 2012
- Identification of Cis-Acting Elements in the 3′-Untranslated Region of the Dengue Virus Type 2 RNA That Modulate Translation and ReplicationJournal of Biological Chemistry, 2011
- Cell Type Specificity and Host Genetic Polymorphisms Influence Antibody-Dependent Enhancement of Dengue Virus InfectionJournal of Virology, 2011
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in HumansScience, 2010
- Methods in Mammalian Autophagy ResearchCell, 2010
- Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle FormationPLOS Pathogens, 2009
- The Atg5–Atg12 conjugate associates with innate antiviral immune responsesProceedings of the National Academy of Sciences, 2007
- Regulated Cleavages at the West Nile Virus NS4A-2K-NS4B Junctions Play a Major Role in Rearranging Cytoplasmic Membranes and Golgi Trafficking of the NS4A ProteinJournal of Virology, 2006
- Subversion of Cellular Autophagosomal Machinery by RNA VirusesPLOS Biology, 2005
- LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processingThe EMBO Journal, 2000